These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 30237106)

  • 1. The dilemma of benign multiple sclerosis: Can we predict the risk of losing the "benign status"? A 12-year follow-up study.
    Razzolini L; Portaccio E; Stromillo ML; Goretti B; Niccolai C; Pastò L; Righini I; Prestipino E; Battaglini M; Giorgio A; De Stefano N; Amato MP
    Mult Scler Relat Disord; 2018 Nov; 26():71-73. PubMed ID: 30237106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropsychological and MRI measures predict short-term evolution in benign multiple sclerosis.
    Portaccio E; Stromillo ML; Goretti B; Zipoli V; Siracusa G; Battaglini M; Giorgio A; Bartolozzi ML; Guidi L; Sorbi S; Federico A; Amato MP; De Stefano N
    Neurology; 2009 Aug; 73(7):498-503. PubMed ID: 19641173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The psychosocial and cognitive impact of longstanding 'benign' multiple sclerosis.
    Sayao AL; Bueno AM; Devonshire V; Tremlett H;
    Mult Scler; 2011 Nov; 17(11):1375-83. PubMed ID: 21677023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can we predict benign multiple sclerosis? Results of a 20-year long-term follow-up study.
    Sartori A; Abdoli M; Freedman MS
    J Neurol; 2017 Jun; 264(6):1068-1075. PubMed ID: 28417192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal follow-up of "benign" multiple sclerosis at 20 years.
    Sayao AL; Devonshire V; Tremlett H
    Neurology; 2007 Feb; 68(7):496-500. PubMed ID: 17296915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benign multiple sclerosis: physical and cognitive impairment follow distinct evolutions.
    Gajofatto A; Turatti M; Bianchi MR; Forlivesi S; Gobbin F; Azzarà A; Monaco S; Benedetti MD
    Acta Neurol Scand; 2016 Mar; 133(3):183-91. PubMed ID: 26009804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural history of benign multiple sclerosis: Clinical and HLA correlates in a Western Australian cohort.
    Fabis-Pedrini MJ; James I; Seewann A; Yau WY; van de Bovenkamp AA; Sanders FRK; Qiu W; Burton J; Mastaglia FL; Carroll WM; Kermode AG
    J Neurol Sci; 2018 May; 388():12-18. PubMed ID: 29627005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors associated with and long-term outcome of benign multiple sclerosis: a nationwide cohort study.
    Crielaard L; Kavaliunas A; Ramanujam R; Olsson T; Hillert J; Stridh P; Kockum I; Manouchehrinia A
    J Neurol Neurosurg Psychiatry; 2019 Jul; 90(7):761-767. PubMed ID: 30824631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient reported outcomes in benign multiple sclerosis.
    Hviid LE; Healy BC; Rintell DJ; Chitnis T; Weiner HL; Glanz BI
    Mult Scler; 2011 Jul; 17(7):876-84. PubMed ID: 21372114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benign multiple sclerosis: a new definition of this entity is needed.
    Correale J; Peirano I; Romano L
    Mult Scler; 2012 Feb; 18(2):210-8. PubMed ID: 21865415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Change in disability in patients with multiple sclerosis: a 20-year prospective population-based analysis.
    Hirst C; Ingram G; Swingler R; Compston DA; Pickersgill T; Robertson NP
    J Neurol Neurosurg Psychiatry; 2008 Oct; 79(10):1137-43. PubMed ID: 18303106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benign multiple sclerosis: a need for a consensus.
    Glad SB; Aarseth JH; Nyland H; Riise T; Myhr KM
    Acta Neurol Scand Suppl; 2010; (190):44-50. PubMed ID: 20586735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term clinical relevance of criteria for designating multiple sclerosis as benign after 10 years of disease.
    Costelloe L; Thompson A; Walsh C; Tubridy N; Hutchinson M
    J Neurol Neurosurg Psychiatry; 2008 Nov; 79(11):1245-8. PubMed ID: 18477712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors associated with benign multiple sclerosis in the New York State MS Consortium (NYSMSC).
    Zivadinov R; Cookfair DL; Krupp L; Miller AE; Lava N; Coyle PK; Goodman AD; Jubelt B; Lenihan M; Herbert J; Gottesman M; Snyder DH; Apatoff BR; Teter BE; Perel AB; Munschauer F; Weinstock-Guttman B
    BMC Neurol; 2016 Jul; 16():102. PubMed ID: 27416843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How common is truly benign MS in a UK population?
    Tallantyre EC; Major PC; Atherton MJ; Davies WA; Joseph F; Tomassini V; Pickersgill TP; Harding KE; Willis MD; Winter M; Robertson NP
    J Neurol Neurosurg Psychiatry; 2019 May; 90(5):522-528. PubMed ID: 30177509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No prognostic value of routine cerebrospinal fluid biomarkers in a population-based cohort of 407 multiple sclerosis patients.
    Becker M; Latarche C; Roman E; Debouverie M; Malaplate-Armand C; Guillemin F
    BMC Neurol; 2015 May; 15():79. PubMed ID: 25966681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is benign MS really benign? What a meaningful classification beyond the EDSS must take into consideration.
    Ellenberger D; Flachenecker P; Haas J; Hellwig K; Paul F; Stahmann A; Warnke C; Zettl UK; Rommer PS;
    Mult Scler Relat Disord; 2020 Nov; 46():102485. PubMed ID: 32980646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MRI features of benign multiple sclerosis: toward a new definition of this disease phenotype.
    Rovaris M; Barkhof F; Calabrese M; De Stefano N; Fazekas F; Miller DH; Montalban X; Polman C; Rocca MA; Thompson AJ; Yousry TA; Filippi M
    Neurology; 2009 May; 72(19):1693-701. PubMed ID: 19433744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In-vivo evidence for stable neuroaxonal damage in the brain of patients with benign multiple sclerosis.
    Benedetti B; Rovaris M; Rocca MA; Caputo D; Zaffaroni M; Capra R; Bertolotto A; Martinelli V; Comi G; Filippi M
    Mult Scler; 2009 Jul; 15(7):789-94. PubMed ID: 19465450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 'Clinically definite benign multiple sclerosis', an unwarranted conceptual hodgepodge: evidence from a 30-year observational study.
    Leray E; Coustans M; Le Page E; Yaouanq J; Oger J; Edan G
    Mult Scler; 2013 Apr; 19(4):458-65. PubMed ID: 22859724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.